Cargando…
Standard coagulation assays alone are not sufficient to exclude surgically relevant rivaroxaban plasma concentrations
BACKGROUND: While mainly larger hospitals have introduced routine anti-Xa assays for rivaroxaban (RXA), these are not readily available to smaller hospitals often relying on routine coagulation tests such as prothrombin time (PT) and activated partial thromboplastin time (aPTT). The aim of our study...
Autores principales: | Kaserer, Alexander, Schedler, Andreas, Seifert, Burkhardt, Spahn, Donat R., Studt, Jan-Dirk, Stein, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864962/ https://www.ncbi.nlm.nih.gov/pubmed/31832179 http://dx.doi.org/10.1186/s13741-019-0128-9 |
Ejemplares similares
-
Comparison of two different coagulation algorithms on the use of allogenic blood products and coagulation factors in severely injured trauma patients: a retrospective, multicentre, observational study
por: Kaserer, Alexander, et al.
Publicado: (2018) -
Point-of-Care Diagnostics in Coagulation Management
por: Sahli, Sebastian D., et al.
Publicado: (2020) -
Impact of a goal-directed factor-based coagulation management on thromboembolic events following major trauma
por: Stein, Anais L., et al.
Publicado: (2019) -
Coronavirus-induced coagulopathy during the course of disease
por: Friedrich, Marie Sophie, et al.
Publicado: (2020) -
Prevalence and outcome of contrast-induced nephropathy in major trauma patients
por: Kelemen, Julian Alexander, et al.
Publicado: (2020)